Although double-negative B cells represent a rare subpopulation in the normal microenvironment, they have been found expanded in the NPC microenvironment and constituted 12.6% of the total CD79A+ B cells, and correlated to worse prognosis (23). The gene discussed is CD79A; the disease is nasopharyngeal carcinoma.